CMINEN will be established as a foundation (stichting) under Dutch law. The three
founding partners of CMINEN (RUG/UMCG, UT and Siemens NL ) will be represented in
this foundation, in accordance with NWO guidelines and subject to approval by NWO and
the relevant regulatory bodies. CMINEN has a simple organizational structure to ensure
proper governance, efficient decision-making and minimal overhead. The governance
structure is presented in the figure below.

Supervisory Board
The Supervisory Board will be CMINEN’s highest governing body and is formed by
the three founding partners. The Supervisory Board is responsible for developing
CMINEN’s strategy, decides on the budget and bears responsibility for the annual report. It determines which corporate partners will participate in CMINEN.
Members of the Supervisory Board are:
Prof. Dr. L.F.M.H. de Leij on behalf of RUG/UMCG
Prof. Dr. G.P. Vooijs on behalf of UTwente
Drs. A.F. van der Touw on behalf of Siemens
Board of Directors
CMINEN’s Board of Directors (clinical and technical scientific director and two managing directors) will manage the day-to-day operations. It will coordinate the research-project groups, monitor their progress and report to the Supervisory Board four times a year. The Board of Directors is responsible for managing CMINEN’s resources. It will control CMINEN’s budget, ensure that project groups have access to the infrastructure and other facilities, and take care of marketing and PR.
Members of the Board of Directors are:
Prof. Dr. M. Oudkerk, Medical Scientific Leader (UMCG)
Prof. Dr. V. Subramaniam, Technical Scientific Leader (UTwente)
Dr. Ir. M. Kuit, Managing Director on behalf of UTwente
Drs. A.J. Kee, Managing Director on behalf of UMCG
Ir. R. Burie, Manager on behalf of UTwente
Drs. E. Jippes, Manager on behalf of UMCG
Dr. E.J.K. Noach, Secretary
Research Committee
The Research Committee is responsible for the design of the CMINEN research programme. The committee will evaluate the research topics proposed by leaders of the CMINEN disciplines of the CMINEN Clinical Advisory Committee on relevance to CMINEN’s strategic goals (criteria include clinical demand, epidemiological soundness, scientific relevance, and time tot translational impact). The Research Committee can propose changes to the research project’s approach in consultation with the CMINEN Clinical Advisory Committee. The Research Committee will also maintain relations with in- and external reviewers, who will be asked to review submitted research proposals for quality and relevance to the development of the project groups. If relevant, new research proposals will be reinforced with solid business cases that confirm clinical and economic values.
Members of the Research Committee are:
Prof. Dr. C.F. Beckmann, Professor Analysis Methods for Neuroscience, UTwente
Prof. Dr. R.A. Dierckx, Professor of Nuclear Medicine, RUG/UMCG
Prof. Dr. M. Oudkerk, Professor of Radiology, RUG/UMCG
Prof. Dr. M. Prokop, Professor of Radiology, UMCN
Prof. Dr. V. Subramaniam, Professor of Nanophysics, UTwente
Discipline group leaders
The leaders of the CMINEN disciplines have extensive experience in various disciplines of medical imaging. They are able to assess whether the research topics proposed include the right medical imaging technologies or the right combination of technologies to achieve the desired results. Health impact modelling, which measures economic and clinical relevance, will support the evaluation of the research proposals.
Discipline group leaders from the UMCG are:
Dr. G.M. van Dam, Minimally invasive and optics
Prof. Dr. E.R. van den Heuvel, Medical Technology Assessment
Dr. Ir. P.M.A. van Ooijen, Medical Imaging Informatics
Dr. R. Vliegenthart Proença, Computed Tomography and X-ray
Prof. Dr. H.P.H. Kremer, Magnetic Resonance Imaging
Dr. R.H.J.A. Slart, Nuclear and Molecular Imaging
Discipline group leaders from the UTwente are:
Prof. Dr. W. Steenbergen, Minimally invasive and optics
Prof. Dr. M.J. IJzerman, Medical Technology Assessment
Prof. Dr. P.M.G. Apers, Medical Imaging Informatics
Prof. Dr. C.H. Slump, Computed Tomography and X-ray
Prof. Dr. D. Norris, Magnetic Resonance Imaging
Prof. Dr. L.W.M. Terstappen, Nuclear and Molecular Imaging
The University Medical Center Groningen, the University of Groningen and the University of Twente have concluded a strategic partnership on ‘Technology and Health'.
CMI has an international focus and is actively pursuing international collaborations. Promising contacts that may lead to new research collaborations and new business are made during the annual Medical Tour. In the last week of November 2012 a delegation of 25 researchers, clinicians and business people affiliated with CMI visited ...
Powered by: YTEC Imaging